📌 Project Title: 

“Support and Increasing Access & Continued Utilization of NCD Quality Drugs and Supplies in All Benefiting Facilities Across Busoga Sub-Region” 

🎯 Project Goal: 

To improve the availability, accessibility, and consistent utilization of quality non-communicable disease (NCD) drugs and essential supplies across health facilities in the Busoga sub-region, thereby enhancing effective management and control of NCDs such as hypertension, diabetes, cancer, and asthma. 

📍 Geographic Focus: 

Busoga Sub-region – covering public and PNFP health facilities across selected districts (e.g., Jinja, Kamuli, Iganga, Bugiri, Mayuge, Namutumba, Kaliro, Luuka, Buyende). 

🔑 Core Program Activities: 

1. Assessment and Mapping of NCD Needs and Facility Gaps 

• Conduct a baseline needs assessment across targeted facilities to identify existing gaps in NCD drug availability, storage, staffing, and equipment. 

• Map out supply chain bottlenecks and consumption trends for NCD medications. 

• Develop a facility-level NCD service inventory. 

2. Procurement and Distribution of Quality NCD Drugs and Supplies 

• Procure essential NCD medicines such as anti-hypertensives, insulin, metformin, salbutamol inhalers, statins, and cancer palliative drugs. 

• Procure NCD-related equipment and supplies, including BP machines, glucometers, strips, nebulizers, weighing scales, and urine dipsticks. 

• Ensure timely distribution and restocking of supplies across benefiting health facilities. 

3. Capacity Building for Health Workers on NCD Case Management 

• Train clinicians, nurses, and pharmacists on standard treatment guidelines (STGs) for NCDs. 

• Provide orientation on rational use of medicines, patient follow-up, and early warning indicators for drug stock-outs. 

• Support ongoing clinical mentorship and supportive supervision in collaboration with DHO teams. 

4. Community Awareness and Demand Generation for NCD Services 

• Conduct community outreaches and radio programs to promote early screening and treatment-seeking behavior for NCDs. 

• Mobilize community health workers and peer champions to support referrals and adherence to NCD drugs. 

• Distribute IEC materials on proper NCD drug use, lifestyle modification, and diet. 

5. Establish and Strengthen Facility-Based NCD Corners 

• Support setup or improvement of NCD care corners within outpatient departments. 

• Equip each facility with patient tracking tools, SOPs, data registers, and counseling space. 

• Link NCD drug dispensing with routine follow-up and review appointments. 

6. Monitoring Drug Utilization, Stock Levels, and Adherence 

• Support implementation of monthly reporting tools (HMIS 029, HMIS 105) focused on NCD drug consumption. 

• Use digital and paper-based systems to track drug stocks and identify early shortages. 

• Promote medication adherence tracking using pill counts, refill records, and patient self-reports. 

7. Stakeholder Engagement and Supply Chain Advocacy 

• Facilitate quarterly stakeholder meetings with NMS, JMS, district health teams, and civil society to discuss supply challenges. 

• Support policy advocacy for increased funding and prioritization of NCD drugs at district and national levels. 

• Strengthen facility-pharmacy linkages and supervision structures for drug accountability. 

👥 Target Beneficiaries: 

• Over 150,000 NCD patients across the Busoga sub-region 

• 100+ health facilities (HC IIIs, HC IVs, General Hospitals) 

• Frontline health workers, pharmacists, and VHTs 

• District Health Teams and Subcounty-level health authorities 

📈 Expected Results: 

• Improved and consistent availability of essential NCD medicines in 100% of targeted facilities 

• Increased NCD patient retention and medication adherence 

• Enhanced capacity of health workers to deliver quality NCD services 

• Strengthened data systems for NCD drug tracking and reporting 

• Greater community awareness and early detection of NCDs 

🌍 Sustainability Measures: 

• Integration of NCD drugs into routine district health budgets 

• Strengthening of last-mile delivery systems in collaboration with NMS and JMS 

• Use of community drug refill agents and VHTs to support home-based follow-up 

• Digital stock management and feedback systems rolled out in collaboration with MOH’s health information systems